Mineral disorders after hematopoietic stem cell transplantation in patients receiving parenteral nutrition
Hematology, Transfusion and Cell Therapy · Published 2026-03-21 · DOI 10.1016/j.htct.2026.106353
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.htct.2026.106353
Abstract
Background: Parenteral nutrition is a critical therapeutic approach for patients undergoing hematopoietic stem cell transplantation. However, parenteral nutrition is associated with complications such as mineral disorders. This study evaluated the prevalence of hypophosphatemia, hypokalemia, and hypomagnesemia in adult transplant patients before and within the first 24 days of parenteral nutrition infusion. Patients and Methods: This retrospective cohort study included patients who underwent hematopoietic stem cell transplantation and required parenteral nutrition at a public quaternary hospital in Brazil between January 2012 and January 2022. Patients were categorized based on indications for parenteral nutrition and specific diagnoses. Laboratory monitoring of phosphorus, potassium, and magnesium levels was performed at predefined intervals during parenteral nutrition infusion, starting at 72 h and during subsequent 4-day intervals until engraftment. Hypophosphatemia, hypokalemia, and hypomagnesemia were defined as levels below established reference values. Descriptive analyses were applied, and the chi-square test, crude odds ratios, and Fisher's exact test were used to compare categorical variables between the periods. Results: The study revealed varying prevalences of hypophosphatemia (21.1–40.3 %), hypokalemia (10.5–31.2 %), and hypomagnesemia (50.0–62.3 %) among the 77 patients included in the study. Severe mineral disorders were observed in only a small proportion of patients. Conclusion: Patients undergoing hematopoietic stem cell transplantation had a high prevalence of mineral depletion throughout the engraftment period.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Related articles
- LIPOSOMAL NANOFORMULATION OF A COPPER-BASED COMPLEX ASSOCIATED WITH PARPI MODULATES ANGIOGENIC PROCESSES IN ENDOTHELIAL CELLS · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- THERANOSTIC APPLICATION OF PSMA IN ADENOID CYSTIC CARCINOMA: ¹⁸F-PSMA PET/CT IMAGING AND ¹⁷⁷LU-PSMA THERAPY — A CASE REPORT · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- Hemovigilance in a Brazilian Amazon blood center: A temporal analysis of 5-year consumption patterns · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- Socio-demographic and therapeutic profile of people living with thalassemia in Brazil between 2012 and 2022: A cross-sectional study · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- EGFR-TARGETING GE11-DERIVED PEPTIDE DIFFERENTIALLY MODULATES TRIPLE-NEGATIVE BREAST CANCER AND GLIOBLASTOMA CELL PROLIFERATION IN VITRO · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- Therapeutic plasma exchange in acute liver failure: Unravelling its efficacy and impact · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- RACIAL DISPARITIES IN BRAZILIAN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: EXPLORATORY ANALYSIS OF EPIDEMIOLOGICAL PROFILE AND IMMUNE SENESCENCE/EXHAUSTION PROTEINS · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- CT-DERIVED BODY COMPOSITION AND MACHINE LEARNING FOR PROGNOSTIC IMPROVEMENT IN COLORECTAL CANCER · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- False-positive test results: prevalence, time trends, and factors associated with false-positive serological markers in blood donation screening · Hematology, Transfusion and Cell Therapy · 2026 · Same journal
- Genetic diversity of the RHD gene in blood donors from the Brazilian Central-West · Hematology, Transfusion and Cell Therapy · 2026 · Same journal